Orion Revenues Increase Despite A Difficult Business Environment In Its Primary Market

BMI Core View: The long-term value of any pharmaceutical company will be driven by maintaining internal research and development (R&D) productivity to ensure a steady rate of product launches, with medicines that offer superior health outcomes and/or improve efficiencies in healthcare delivery systems. However, the competitive environment in core pharmaceutical markets is changing rapidly - with generic drugs increasing and patented drugs decreasing their shares of the

To read the full article, please choose one of the following options: